MAY 8·Stock TitanMed
Grove Collaborative (GROV) raises 2026 guidance as Q1 EBITDA turns positive
Grove Collaborative (GROV) reported Q1 2026 net revenue of $36.2 million, a 16.8% year-over-year decline, but achieved positive Adjusted EBITDA of $0.3 million. The company narrowed its net loss to $1.0 million and improved its gross margin to 54.8%. Consequently, Grove Collaborative has raised its full-year 2026 net revenue guidance to $142.5–$152.5 million and expects Adjusted EBITDA to be between breakeven and positive low single digits, anticipating sequential revenue improvement after Q1 marked the expected trough.